EKF introduces accurate quantitative Covid-19 antibody test kit
EKF Diagnostics, a global in vitro diagnostics company based in Penarth, has introduced one of the first tests to precisely measure levels of Covid-19 neutralising antibodies in individuals. Unlike other antibody tests, MediWales reports the Kantaro COVID-SeroKlir SARS-CoV-2 IgG antibody test kit determines both the presence and specific quantities of human IgG antibodies to the … Continue reading EKF introduces accurate quantitative Covid-19 antibody test kit
EKF dividend to facilitate Trellus spin-out
Penarth based EKF Diagnostics is to update shareholders on a dividend in specie which will facilitate the spin-out of the company’s shareholding in Trellus Health. Trellus provides digital health services for people with complex chronic conditions. Insider Media reports EKF made a $5m investment in the business, which is headquartered in New York and has … Continue reading EKF dividend to facilitate Trellus spin-out
EKF secures new orders for Covid-19 collection kits
Specialist manufacturer EKF has received two orders for Covid-19 sample collection kits. Insider Media reports the Penarth headquartered business has secured two new customers for the PrimeStore MTM Covid-19 sample collection devices; Health Service Executive Ireland and a national health body in England. The tests will be made at EKF’s facilities in Penarth and Barleben, … Continue reading EKF secures new orders for Covid-19 collection kits
EKF Diagnostics set for record month
Penarth based EKF Diagnostics is on track for a record month thanks to growth from its core business and continued demand for Covid-19 sample collection kits. Insider Media reports EKF said a significantly improved performance in the core business based on October orders, together with the PrimeStore MTM Covid-19 sample collection device, meant revenues and … Continue reading EKF Diagnostics set for record month
EKF Diagnostics invests in digital health platform
Penarth based EKF Diagnostics has invested $5m into a resilience driven digital health service for complex chronic conditions. MediWales reports the investment in the Trellus Health platform will be used to support the newly incorporated company’s work to transform the way chronic conditions are treated, with an initial focus on inflammatory bowel disease (IBD), including … Continue reading EKF Diagnostics invests in digital health platform
EKF’s revenue exceeds expectations due to demand for Covid-19 sample collection
EKF Diagnostics has said it is set to outstrip revised forecasts with the growth largely due to high demand for the PrimeStore MTM Device, which is used for safe Covid-19 sample collection. PrimesStore MTM is manufactured by the business under contract in the US and UK. Back in May EKF set expectations of revenues of … Continue reading EKF’s revenue exceeds expectations due to demand for Covid-19 sample collection
Life sciences sector can have bigger impact on Welsh economy says EKF Diagnostics CEO
The chief executive of one of Wales’ leading life sciences companies says the sector has an opportunity to have a much bigger impact on the economy, providing the Welsh Government reaches out more. Penarth born Julian Baines has over twenty years of experience within the life sciences sector, having acquired EKF Diagnostics in 2010 through … Continue reading Life sciences sector can have bigger impact on Welsh economy says EKF Diagnostics CEO
EKF raises £22.25m with RenalytixAI placing
Penarth-headquartered medical equipment company EKF has raised a total of £22.25m with the listing of a spin-out company after receiving proceeds from a restricted offer to current shareholders. Insider Media reports RenalytixAI received valid applications from qualifying EKF shareholders in respect of 1,223,952 RENX Shares, representing gross proceeds of approximately £1.48m. The allotment and issue … Continue reading EKF raises £22.25m with RenalytixAI placing
RenalytixAI raises £21m through share placing
RenalytixAI, a spin-out from Welsh medical diagnostics company EKF Diagnostics, has raised £21m through a placing. The company plans to list on AIM. Insider Media reports the share issue values RenalytixAI, a developer of AI enabled clinical decision support solutions for kidney disease, at £63.9m. The company, which plans to launch a further restricted offer … Continue reading RenalytixAI raises £21m through share placing
EKF analyser used by nurses in Ghana
The Eleanor Mann School of Nursing at the University of Arkansas took fifteen nursing students to study abroad in Bolgatanga, Ghana in Summer 2017. Working at a small village clinic they discovered that anaemia is very common and sometimes leads to blood transfusions, but more commonly, death. A new team has returned this summer to … Continue reading EKF analyser used by nurses in Ghana
